Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 7,453Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6Ascent Innovative Medicines

02 2Aurobindo Pharma Limited

03 2Hetero Drugs

04 2Hikma Pharmaceuticals

05 8MSD Pharmaceuticals

06 6Merck & Co

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Hospitalar
Not Confirmed
arrow
arrow
Hospitalar
Not Confirmed

ertugliflozin

Brand Name :

Dosage Form : Tablet

Dosage Strength : 5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

02

Hospitalar
Not Confirmed
arrow
arrow
Hospitalar
Not Confirmed

ertugliflozin

Brand Name :

Dosage Form : Tablet

Dosage Strength : 15MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

03

Hospitalar
Not Confirmed
arrow
arrow
Hospitalar
Not Confirmed

Ertugliflozin; Sitagliptin Phosphate

Brand Name :

Dosage Form :

Dosage Strength : 2.5MG; 500MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

04

Hospitalar
Not Confirmed
arrow
arrow
Hospitalar
Not Confirmed

Ertugliflozin; Sitagliptin Phosphate

Brand Name :

Dosage Form :

Dosage Strength : 2.5MG; 1G

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

05

Hospitalar
Not Confirmed
arrow
arrow
Hospitalar
Not Confirmed

Ertugliflozin; Sitagliptin Phosphate

Brand Name :

Dosage Form :

Dosage Strength : 7.5MG; 500MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

06

Hospitalar
Not Confirmed
arrow
arrow
Hospitalar
Not Confirmed

Ertugliflozin; Sitagliptin Phosphate

Brand Name :

Dosage Form :

Dosage Strength : 7.5MG; 1G

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

07

Hospitalar
Not Confirmed
arrow
arrow
Hospitalar
Not Confirmed

ERTUGLIFLOZIN

Brand Name : ERTUGLIFLOZIN

Dosage Form : TABLET;ORAL

Dosage Strength : 5MG

Packaging :

Approval Date : 2023-07-13

Application Number : 216947

Regulatory Info : DISCN

Registration Country : USA

blank

08

Hospitalar
Not Confirmed
arrow
arrow
Hospitalar
Not Confirmed

ERTUGLIFLOZIN

Brand Name : ERTUGLIFLOZIN

Dosage Form : TABLET;ORAL

Dosage Strength : 15MG

Packaging :

Approval Date : 2023-07-13

Application Number : 216947

Regulatory Info : DISCN

Registration Country : USA

blank

09

Hospitalar
Not Confirmed
arrow
arrow
Hospitalar
Not Confirmed

ERTUGLIFLOZIN

Brand Name : ERTUGLIFLOZIN

Dosage Form : TABLET;ORAL

Dosage Strength : 5MG

Packaging :

Approval Date : 2024-09-17

Application Number : 217071

Regulatory Info : RX

Registration Country : USA

blank

10

Hospitalar
Not Confirmed
arrow
arrow
Hospitalar
Not Confirmed

ERTUGLIFLOZIN

Brand Name : ERTUGLIFLOZIN

Dosage Form : TABLET;ORAL

Dosage Strength : 15MG

Packaging :

Approval Date : 2024-09-17

Application Number : 217071

Regulatory Info : RX

Registration Country : USA

blank

11

Hospitalar
Not Confirmed
arrow
arrow
Hospitalar
Not Confirmed

ERTUGLIFLOZIN

Brand Name : ERTUGLIFLOZIN

Dosage Form : TABLET;ORAL

Dosage Strength : 5MG

Packaging :

Approval Date : 2025-01-21

Application Number : 216842

Regulatory Info : DISCN

Registration Country : USA

blank

12

Hospitalar
Not Confirmed
arrow
arrow
Hospitalar
Not Confirmed

ERTUGLIFLOZIN

Brand Name : ERTUGLIFLOZIN

Dosage Form : TABLET;ORAL

Dosage Strength : 15MG

Packaging :

Approval Date : 2025-01-21

Application Number : 216842

Regulatory Info : DISCN

Registration Country : USA

blank

13

Hospitalar
Not Confirmed
arrow
arrow
Hospitalar
Not Confirmed

ERTUGLIFLOZIN

Brand Name : STEGLATRO

Dosage Form : TABLET;ORAL

Dosage Strength : 5MG

Packaging :

Approval Date : 2017-12-19

Application Number : 209803

Regulatory Info : RX

Registration Country : USA

blank

14

Hospitalar
Not Confirmed
arrow
arrow
Hospitalar
Not Confirmed

ERTUGLIFLOZIN

Brand Name : STEGLATRO

Dosage Form : TABLET;ORAL

Dosage Strength : 15MG

Packaging :

Approval Date : 2017-12-19

Application Number : 209803

Regulatory Info : RX

Registration Country : USA

blank

15

Hospitalar
Not Confirmed
arrow
arrow
Hospitalar
Not Confirmed

ERTUGLIFLOZIN; SITAGLIPTIN PHOSPHATE

Brand Name : STEGLUJAN

Dosage Form : TABLET;ORAL

Dosage Strength : 5MG;EQ 100MG BASE

Packaging :

Approval Date : 2017-12-19

Application Number : 209805

Regulatory Info : RX

Registration Country : USA

blank

16

Hospitalar
Not Confirmed
arrow
arrow
Hospitalar
Not Confirmed

ERTUGLIFLOZIN; SITAGLIPTIN PHOSPHATE

Brand Name : STEGLUJAN

Dosage Form : TABLET;ORAL

Dosage Strength : 15MG;EQ 100MG BASE

Packaging :

Approval Date : 2017-12-19

Application Number : 209805

Regulatory Info : RX

Registration Country : USA

blank

17

Hospitalar
Not Confirmed
arrow
arrow
Hospitalar
Not Confirmed

ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE

Brand Name : SEGLUROMET

Dosage Form : TABLET;ORAL

Dosage Strength : 2.5MG;500MG

Packaging :

Approval Date : 2017-12-19

Application Number : 209806

Regulatory Info : RX

Registration Country : USA

blank

18

Hospitalar
Not Confirmed
arrow
arrow
Hospitalar
Not Confirmed

ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE

Brand Name : SEGLUROMET

Dosage Form : TABLET;ORAL

Dosage Strength : 2.5MG;1GM

Packaging :

Approval Date : 2017-12-19

Application Number : 209806

Regulatory Info : RX

Registration Country : USA

blank

19

Hospitalar
Not Confirmed
arrow
arrow
Hospitalar
Not Confirmed

ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE

Brand Name : SEGLUROMET

Dosage Form : TABLET;ORAL

Dosage Strength : 7.5MG;500MG

Packaging :

Approval Date : 2017-12-19

Application Number : 209806

Regulatory Info : RX

Registration Country : USA

blank

20

Hospitalar
Not Confirmed
arrow
arrow
Hospitalar
Not Confirmed

ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE

Brand Name : SEGLUROMET

Dosage Form : TABLET;ORAL

Dosage Strength : 7.5MG;1GM

Packaging :

Approval Date : 2017-12-19

Application Number : 209806

Regulatory Info : RX

Registration Country : USA

blank